BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
11.04
+0.33 (3.08%)
At close: Sep 26, 2025, 4:00 PM EDT
10.98
-0.06 (-0.54%)
After-hours: Sep 26, 2025, 7:22 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $19.42 million as of September 26, 2025. Its market cap has increased by 66.01% in one year.
Market Cap
19.42M
Enterprise Value
6.60M
1-Year Change
66.01%
Ranking
Category
Stock Price
$11.04
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $19.42M, a decrease of -25.30%. That is a compound annual growth rate of -6.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 7.50M | -70.00% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |